This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
RETRACTED: Fusco et al. Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Inhibitor as a Novel Therapeutic Tool for Lung Injury. Int. J. Mol. Sci. 2020, 21, 7761
Roberta Fusco, Rosalba Siracusa, Ramona D’Amico, Marika Cordaro, Tiziana Genovese, Enrico Gugliandolo, Alessio Filippo Peritore, Rosalia Crupi, Rosanna Di Paola, Salvatore Cuzzocrea, Daniela Impellizzeri

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCell death mechanisms and regulation · Lymphoma Diagnosis and Treatment · Galectins and Cancer Biology
The journal retracts the article “Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Inhibitor as a Novel Therapeutic Tool for Lung Injury” [1] cited above.
Following publication, concerns were brought to the attention of the Editorial Office regarding the integrity of images presented in this publication [1].
Adhering to our standard procedure, an investigation was conducted by the Editorial Office and Editorial Board that identified indications of inappropriate editing and partial duplication between micrographs in Figure 1C,D in this article [1]. While the authors collaborated within this process, raw material meeting the journals requirements for original images could not be provided for Editorial Board Evaluation. Consequently, the Editorial Board has lost confidence in the reliability of the findings and has decided to retract this publication, as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30, accessed on 9 March 2026).
This retraction was approved by the Editor-in-Chief of the International Journal of Molecular Sciences.
The authors disagreed with this retraction.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Fusco R. Siracusa R. D’Amico R. Cordaro M. Genovese T. Gugliandolo E. Peritore A.F. Crupi R. Di Paola R. Cuzzocrea S. RETRACTED: Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Inhibitor as a Novel Therapeutic Tool for Lung Injury Int. J. Mol. Sci.202021776110.3390/ijms 2120776133092214 PMC 7589767 · doi ↗ · pubmed ↗
